In2Bones Announces U.S. Launch of the Avenger Radial Head™ Prosthesis With Sterile, Single-Use Instruments

February 13, 2020 

MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announces the U.S. launch of the Avenger Radial Head™ Prosthesis System for primary and revision joint replacement of the radial head. The new prosthesis restores elbow joint function, and provides several advantages to surgeons and patients compared with current prosthetic systems. It is the first radial head implant to include sterile, single-use instrumentation.

The modularity of the new Avenger Radial Head Prosthesis System — with multiple, highly-polished head and stem sizes — enables surgeons to restore the appropriate height of the radius, which may aid in elbow stability. The new System is also designed with a smooth stem, shown in multiple long-term studies to provide better clinical outcomes than press-fit, ingrowth radial head implant designs.1, 2

The elbow joint is often difficult to access during surgery due to swelling and inflammation caused by trauma. The Avenger System resolves this with tapered and short stem options, allowing for easier insertion and improved implant stability.

“I choose smooth stem radial head implants for my patients because they have shown to have better long-term results,” says Korsh Jafarnia, M.D., orthopedic surgeon and specialist in the hand and upper extremities at Houston Methodist Orthopedics & Sports Medicine. “The In2Bones Avenger Radial Head System is a modern, smooth stem design that is easier to implant due to the tapered and shorter stems.”

Savings from Single-Use Instrument Sets

Radial head replacements are often performed during trauma surgery with little advanced notice. Thus, there can be tremendous benefits to providers who select implants that include sterile, single-use instruments. Benefits include:

  • Cost savings of as much as $400 per surgery
  • Increased efficiencies because long lead times and delays related to on-site sterilizing processes are bypassed
  • Reduced risks of surgical site infections (SSIs) post-operatively

“Having the instruments and implants sterile and ready to use provides costs savings for my hospital, and assures me that the system will be ready when I’m called in for surgery,” Dr. Jafarnia notes.

“Currently, radial head implant suppliers ship non-sterile instrument sets nationwide for short-notice cases, which can cause potential delays and can increase costs,” explains Jon Simon, Sr. Vice President of Marketing at In2Bones. “The Avenger Radial Head System can be placed on shelves and be ready for immediate use, on-demand. Additionally, surgeons and caregivers can be assured that the sharp, precision instrumentation will only ever contact one patient.”

For more information about the new Avenger Radial Head Prosthesis System or other In2Bones Global, Inc. extremity products, please visit www.In2Bones.com.

About In2Bones

Headquartered in Memphis, Tennessee, In2Bones is a global designer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. For more information, visit www.in2bones.com.

Safe-Harbor Statement:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management’s current view of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “will,” and other similar terms. The company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties impacting the business, including increased competition, technical obsolescence, regulatory issues, general economic conditions and other risks.

1. T. Flinkkilä, T. Kaisto, K. Sirniö, P. Hyvönen, J. Leppilahti, J. of Bone and Joint Surgery, Short- to mid-term results of metallic press-fit radial head arthroplasty in unstable injuries of the elbow. VOL. 94-B, No. 6, JUNE 2012.

2. Grewal; J. Bone Joint Surg. 2006;88:2192-2200


Media Contacts:
Jon Simon, Sr. Vice President of Marketing
In2Bones USA
6000 Poplar Ave, Suite 115 Memphis, TN 38119
O: 901.260.7931 • F: 844-712-6637
Email: jsimon@i2b-usa.com
Bob Reed
Element-R Partners

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button